Skip to main content
logo
LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
5.48
+0.43 (8.51%)
At close: Jul 24, 2026, 4:00 PM EDT
5.38
-0.10 (-1.82%)
After-hours: Jul 24, 2026, 7:34 PM EDT

LENZ Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
20.9919.09----
Revenue Growth
------
Gross Profit
20.9918.67----
Operating Income
-118.34-91.14-58.61-72.43-105.64-60.44
Net Income
-109-82.13-49.77-69.97-101.05-70.76
Earnings Per Share
-3.60-2.85-2.34-35.71-24.46-17.15
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
258.39292.35209.0365.79268.23376.98
Total Debt
0.240.350.810.195.7911.28
Net Cash (Debt)
258.15292208.2265.6262.44365.7
Net Cash Growth
33.55%40.24%217.39%-75.00%-28.24%1748.65%
Net Cash Per Share
8.6710.139.7815.8863.5288.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-86.7-69.17-59.39-60.38-87.98-52.85
Capital Expenditures
-0.74-0.83-0.47-0.03-6.59-5.74
Free Cash Flow
-87.44-70-59.86-60.41-94.57-58.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%97.81%----
Operating Margin
-563.83%-477.46%----
Pretax Margin
-516.91%-427.62%----
Profit Margin
-519.30%-430.25%----
FCF Margin
-416.59%-366.71%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.1926.27----